about
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice.Extravasation of Pt-based chemotherapeutics - bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS).Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.LA-ICP-MS imaging in multicellular tumor spheroids - a novel tool in the preclinical development of metal-based anticancer drugs.Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research.In vitro assessment of the antimicrobial activity of silver and zinc oxide nanoparticles against fish pathogens.The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation.X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.Fast High-Resolution Laser Ablation-Inductively Coupled Plasma Mass Spectrometry Imaging of the Distribution of Platinum-Based Anticancer Compounds in Multicellular Tumor Spheroids.Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action.The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS.Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidneySilver nanoparticles: Their role as antibacterial agent against Aeromonas salmonicida subsp. salmonicida in rainbow trout (Oncorhynchus mykiss)Critical assessment of different methods for quantitative measurement of metallodrug-protein associationsQuantitative Imaging of Silver Nanoparticles and Essential Elements in Thin Sections of Fibroblast Multicellular Spheroids by High Resolution Laser Ablation Inductively Coupled Plasma Time-of-Flight Mass SpectrometryImaging of Ag NP transport through collagen-rich microstructures in fibroblast multicellular spheroids by high-resolution laser ablation inductively coupled plasma time-of-flight mass spectrometryMercury, silver, selenium and other trace elements in three cyprinid fish species from the Vaal Dam, South Africa, including implications for fish consumersLaser Ablation-Inductively Coupled Plasma Time-of-Flight Mass Spectrometry Imaging of Trace Elements at the Single-Cell Level for Clinical PracticeFI-ICP-TOFMS for quantification of biologically essential trace elements in cerebrospinal fluid - high-throughput at low sample volumeLaser ablation-ICP-TOFMS imaging of germ cell tumors of patients undergoing platinum-based chemotherapy
P50
Q35154370-5722DFFB-D319-4A88-87A7-FB6A06140137Q35154374-A8F07668-B6B5-4FBE-BA0A-A8844E1B38B5Q35167846-2F2FF5C6-F376-472F-9249-090BD903ED28Q35557391-8CA8F3E9-FFBC-4DBA-95B2-E8D71859CBF9Q35598162-37C443C1-3D7C-4188-BA1C-31C278068BE6Q35902867-E9C35BA9-2174-4467-A462-D4DDC02896E6Q36268494-45D0FF0A-FF47-455D-B51E-F1A22953E327Q38653612-EF809B5D-6E9C-4193-8B0B-5EE308AD0FACQ38779973-525C0CA3-789D-49DA-9644-F469ACDABFF3Q38795441-8B0E0647-F1EC-4402-81C5-40908BA054D1Q39753526-C91191C7-4C51-4111-9231-7CEA4A46A4E3Q39773916-854C4811-941D-48CD-B44E-99A1CB39DDF0Q48361696-582EA568-2610-47D6-93B5-50888106C559Q50015296-5B8E11B5-8F0E-4E59-AA63-CAC1C5DC99BDQ51737285-36B82AD5-BAEC-476B-9293-768FC3BFCB7BQ52669693-AA371881-DA18-427F-A7BB-5A304E8825A5Q57900919-285093C5-511D-4CA4-ACC8-575EC1799DAEQ89349812-7E6A47B0-A29B-41A5-8E7D-49CD2EA4DAB2Q91192394-E128FDA3-6012-4A68-B8BE-CF88410B228BQ91545137-EC4BACDE-B6E0-4480-AA08-7EEAD8FFD3D1Q91951791-1B78462F-688E-4D32-AABE-E10961D9B04DQ92080385-39822920-F7C4-4C75-8239-6634DB0608B1Q92242054-1F93F2B7-3B7D-4CA9-BE27-C2579663E485Q93139783-18069D64-757C-4B9C-B0E5-146494C0348EQ96290833-A11D2910-284C-485A-88CF-97B136CF5FEB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sarah Theiner
@en
Sarah Theiner
@nl
type
label
Sarah Theiner
@en
Sarah Theiner
@nl
prefLabel
Sarah Theiner
@en
Sarah Theiner
@nl
P31
P496
0000-0001-5301-0139